Skip to main content

Table 1 Prescription drug expenditures by insurance and age in the United States

From: Healthcare reform in the United States and China: pharmaceutical market implications

 

2010

2015

2020

 

Population

Rx (per capita)

Population

Rx (per capita)

Population

Rx (per capita)

Under 26

108,528,000

 

110,205,000

 

110,680,000

 

 Private insurance

63,602,000

209

68,737,000

300

69,033,000

431

 Public insurance only

32,192,000

368

37,139,000

528

37,631,000

758

 Uninsured

12,734,000

109

4,329,000

156

4,016,000

225

26-64

158,889,000

 

163,463,000

 

167,247,000

 

 Private Insurance

115,778,000

915

127,838,000

1,314

136,923,000

1,886

 Public Insurance only

15,619,000

2,376

22,558,000

3,411

23,582,000

4,897

 Uninsured

27,492,000

275

13,068,000

395

6,742,000

567

65 and over

41,158,000

 

47,695,000

 

55,969,000

 

 Medicare only

15,683,000

2,036

18,174,000

2,923

21,327,000

4,196

 Medicare and private

20,799,000

2,350

24,102,000

3,374

28,284,000

4,843

 Medicare and other public

4,062,000

2,953

4,707,000

4,239

5,524,000

6,086

 Uninsured

614,000

1,577

711,000

2,264

835,000

3,250

Total

308,575,000

270,907

321,363,000

446,956

333,896,000

699,517

  1. Note: Population is actual or projected number rounded to nearest thousand; total prescription drug (Rx) spending is in millions of US$, nominal.
  2. Sources: U.S. Census Bureau, “Projections of the Population by Selected Age Groups: 2010 to 2050”, (May 2013); Agency for Healthcare Research and Quality, “Medical Expenditure Panel Survey: Prescription Medicines Expenses per Person by Source of Payment” (May 2013).